Jazz Pharmaceuticals Acquires Pre-clinical Pan-RAF Inhibitor Program from Redx Pharma
Go back to Jazz Pharmaceuticals Acquires Pre-clinical Pan-RAF Inhibitor Program from Redx Pharma| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 246.38 -4.72 (1.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $251.10 | 52 Week High | $160.00 | |||
| Open | $249.48 | 52 Week Low | $95.80 | |||
| Day High | $250.64 | P/E | 45.80 | |||
| Day Low | $245.00 | EPS | $5.38 | |||
| Volume | 640,966 | |||||
